PMC:7324763 / 70558-73497 14 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1125 | 61-65 | UBERON:0000104 | denotes | life |
| T94462 | 61-65 | UBERON:0000104 | denotes | life |
| T1126 | 78-89 | UBERON:0001004 | denotes | respiratory |
| T21527 | 78-89 | UBERON:0001004 | denotes | respiratory |
| T1127 | 132-140 | SP_7 | denotes | COVID-19 |
| T62945 | 132-140 | SP_7 | denotes | COVID-19 |
| T1128 | 145-149 | PR:000001379 | denotes | IL-2 |
| T50145 | 145-149 | PR:000001379 | denotes | IL-2 |
| T1129 | 151-155 | PR:000001393 | denotes | IL-6 |
| T60573 | 151-155 | PR:000001393 | denotes | IL-6 |
| T1130 | 163-168 | PR:000001471 | denotes | IL-10 |
| T25419 | 163-168 | PR:000001471 | denotes | IL-10 |
| T1131 | 170-175 | PR:000005932 | denotes | G-CSF |
| T92622 | 170-175 | PR:000005932 | denotes | G-CSF |
| T1132 | 177-182 | PR:000006064 | denotes | IP-10 |
| T42083 | 177-182 | PR:000006064 | denotes | IP-10 |
| T1133 | 184-189 | PR:000002122 | denotes | MCP-1 |
| T56542 | 184-189 | PR:000002122 | denotes | MCP-1 |
| T1134 | 191-196 | PR:000002123 | denotes | MIP1A |
| T78467 | 191-196 | PR:000002123 | denotes | MIP1A |
| T1135 | 202-207 | PR:000000134 | denotes | TNF-α |
| T77395 | 202-207 | PR:000000134 | denotes | TNF-α |
| T1136 | 262-266 | PR:000001393;GO:1990774 | denotes | IL-6 |
| T22872 | 262-266 | PR:000001393;GO:1990774 | denotes | IL-6 |
| T1137 | 267-276 | GO:1990774 | denotes | signaling |
| T68438 | 267-276 | GO:1990774 | denotes | signaling |
| T1138 | 287-292 | PR:000001394 | denotes | IL-6R |
| T86516 | 287-292 | PR:000001394 | denotes | IL-6R |
| T1139 | 304-314 | GO:0042571 | denotes | antibodies |
| T58110 | 304-314 | GO:0042571 | denotes | antibodies |
| T1140 | 322-333 | DG_35 | denotes | tocilizumab |
| T84142 | 322-333 | DG_35 | denotes | tocilizumab |
| T1141 | 335-344 | DG_39 | denotes | sarilumab |
| T66444 | 335-344 | DG_39 | denotes | sarilumab |
| T1142 | 388-392 | PR:000001393 | denotes | IL-6 |
| T86879 | 388-392 | PR:000001393 | denotes | IL-6 |
| T1143 | 423-434 | DG_35 | denotes | Tocilizumab |
| T17230 | 423-434 | DG_35 | denotes | Tocilizumab |
| T1144 | 593-599 | CL:0000084 | denotes | T cell |
| T41445 | 593-599 | CL:0000084 | denotes | T cell |
| T1145 | 660-671 | DG_35 | denotes | tocilizumab |
| T14661 | 660-671 | DG_35 | denotes | tocilizumab |
| T1146 | 699-707 | SP_7 | denotes | COVID-19 |
| T6591 | 699-707 | SP_7 | denotes | COVID-19 |
| T1147 | 791-795 | PR:000001393 | denotes | IL-6 |
| T28888 | 791-795 | PR:000001393 | denotes | IL-6 |
| T1148 | 952-963 | CHEBI:17578;DG_35;CHEBI:17578 | denotes | tocilizumab |
| T87423 | 952-963 | CHEBI:17578;DG_35;CHEBI:17578 | denotes | tocilizumab |
| T1149 | 1074-1082 | SP_7 | denotes | COVID-19 |
| T75574 | 1074-1082 | SP_7 | denotes | COVID-19 |
| T1150 | 1118-1122 | PR:000001393 | denotes | IL-6 |
| T52858 | 1118-1122 | PR:000001393 | denotes | IL-6 |
| T1151 | 1138-1146 | SP_7 | denotes | COVID-19 |
| T96492 | 1138-1146 | SP_7 | denotes | COVID-19 |
| T1152 | 1240-1244 | PR:000001393 | denotes | IL-6 |
| T68233 | 1240-1244 | PR:000001393 | denotes | IL-6 |
| T1153 | 1310-1321 | DG_35 | denotes | tocilizumab |
| T90246 | 1310-1321 | DG_35 | denotes | tocilizumab |
| T1154 | 1412-1417 | UBERON:0001977 | denotes | serum |
| T34027 | 1412-1417 | UBERON:0001977 | denotes | serum |
| T1155 | 1418-1422 | PR:000001393 | denotes | IL-6 |
| T1580 | 1418-1422 | PR:000001393 | denotes | IL-6 |
| T1156 | 1492-1500 | SP_7 | denotes | COVID-19 |
| T78882 | 1492-1500 | SP_7 | denotes | COVID-19 |
| T1157 | 1550-1558 | SP_7 | denotes | COVID-19 |
| T21963 | 1550-1558 | SP_7 | denotes | COVID-19 |
| T1158 | 1632-1642 | PR:000003502 | denotes | granzyme A |
| T58565 | 1632-1642 | PR:000003502 | denotes | granzyme A |
| T1159 | 1663-1674 | DG_35 | denotes | tocilizumab |
| T42323 | 1663-1674 | DG_35 | denotes | tocilizumab |
| T1160 | 1744-1752 | SP_7 | denotes | COVID-19 |
| T20026 | 1744-1752 | SP_7 | denotes | COVID-19 |
| T1161 | 1961-1969 | SP_7 | denotes | COVID-19 |
| T97148 | 1961-1969 | SP_7 | denotes | COVID-19 |
| T1162 | 2088-2093 | UBERON:0000178 | denotes | blood |
| T9491 | 2088-2093 | UBERON:0000178 | denotes | blood |
| T1163 | 2171-2180 | CHEBI:36357;CHEBI:36357 | denotes | molecules |
| T48025 | 2171-2180 | CHEBI:36357;CHEBI:36357 | denotes | molecules |
| T1164 | 2321-2329 | CHEBI:82594;CHEBI:82594 | denotes | Ferritin |
| T24605 | 2321-2329 | CHEBI:82594;CHEBI:82594 | denotes | Ferritin |
| T1165 | 2334-2338 | PR:000001393 | denotes | IL-6 |
| T40047 | 2334-2338 | PR:000001393 | denotes | IL-6 |
| T1166 | 2402-2408 | CL:0000084 | denotes | T cell |
| T77506 | 2402-2408 | CL:0000084 | denotes | T cell |
| T1167 | 2424-2428 | PR:000009196 | denotes | Jak1 |
| T91493 | 2424-2428 | PR:000009196 | denotes | Jak1 |
| T1168 | 2431-2441 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T58584 | 2431-2441 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T1169 | 2504-2512 | SP_7 | denotes | COVID-19 |
| T50670 | 2504-2512 | SP_7 | denotes | COVID-19 |
| T1170 | 2531-2542 | DG_41 | denotes | baricitinib |
| T22229 | 2531-2542 | DG_41 | denotes | baricitinib |
| T1171 | 2615-2619 | PR:000001393 | denotes | IL-6 |
| T68856 | 2615-2619 | PR:000001393 | denotes | IL-6 |
| T1172 | 2697-2708 | GO:0072583 | denotes | endocytosis |
| T24099 | 2697-2708 | GO:0072583 | denotes | endocytosis |
| T1173 | 2826-2837 | DG_41 | denotes | baricitinib |
| T60677 | 2826-2837 | DG_41 | denotes | baricitinib |
| T1174 | 2921-2929 | SP_7 | denotes | COVID-19 |
| T73273 | 2921-2929 | SP_7 | denotes | COVID-19 |